Search

Pain Drug Race Continues as Regeneron Posts Early Phase 3 Results

PAIN DRUG RACE CONTINUES AS REGENERON POSTS EARLY PHASE 3 RESULTS

A new class of pain drugs that might offer an alternative to addictive opioids-if they're safe enough to use chronically-is inching...

Elanco's IPO Would Free Eli Lilly to Focus on Pharmaceuticals

ELANCO'S IPO WOULD FREE ELI LILLY TO FOCUS ON PHARMACEUTICALS

Elanco, the animal health business of Eli Lilly, has filed for an IPO, setting in motion the process of splitting from its parent company...

 
 
 
Bio Roundup: Alnylam's Moment, Read on Rebates, Skinny Plans & More

BIO ROUNDUP: ALNYLAM'S MOMENT, READ ON REBATES, SKINNY PLANS & MORE

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren't taking a break from the gamesmanship...

Profit surges at Pfizer in 2Q on lower taxes, drug sales

PROFIT SURGES AT PFIZER IN 2Q ON LOWER TAXES, DRUG SALES

Pfizer's second-quarter profit surged 26 percent, thanks to a 4 percent increase in medicine sales, higher income from partnerships...

 
 
 

SENIOR PRINCIPAL SCIENTIST, STRATEGIC ALLIANCES - PFIZER INC. - LA JOLLA, CA

Depending on the nature of the partnership, the Senior Principal Scientist will independently build, develop, and manage all or parts...

 
 
 
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

BIO ROUNDUP: DRUG PRICES, CRISPR CAVEATS, RUBIUS IPO POP & MORE

After nearly two years of all smoke, no fire around President Trump's promise to curtail drug prices, there's finally some glimmer...

 
 
 
Pfizer is holding off on price increases to some of its drugs after being singled out by Trump

PFIZER IS HOLDING OFF ON PRICE INCREASES TO SOME OF ITS DRUGS AFTER BEING SINGLED OUT BY TRUMP

President Donald Trump singled out pharma giant Pfizer on Monday in a tweet about drug pricing. Pfizer had increased the price of 100...

 
 
 
As Sarepta Preps Data, FDA Lifts Hold on Solid's Duchenne Gene Therapy

AS SAREPTA PREPS DATA, FDA LIFTS HOLD ON SOLID'S DUCHENNE GENE THERAPY

The race to use gene therapy to treat Duchenne muscular dystrophy, a progressive, deadly genetic disease that affects boys, is heating...

 
 
 
Pharma giants like Novartis, Pfizer, and Sanofi are getting serious about a cutting edge therapy that changes human genes

PHARMA GIANTS LIKE NOVARTIS, PFIZER, AND SANOFI ARE GETTING SERIOUS ABOUT A CUTTING EDGE THERAPY THAT CHANGES HUMAN GENES

Pharma is getting serious about gene therapy, one-time treatments that modify genes to potentially cure serious diseases. Novartis...

 
 
 
 
 
 
 
 
 
Lilly Licenses Sigilon's Cell Encapsulation Tech for Diabetes Therapy

LILLY LICENSES SIGILON'S CELL ENCAPSULATION TECH FOR DIABETES THERAPY

A day after Pfizer decided to step back from the development of a universal cell therapy for cancer, Eli Lilly is jumping in, this...